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ABsTRACT
In this study we set out to analyze the kinetics of activation-induced regulation of 
four miRNA, i.e. miR-21, miR-146a, miR-155, and miR-31 in primary CD4+ T-cells. 
Differential expression of these miRNAs in sorted naive and memory CD4+ T cells 
was assessed. Next, the dynamics of the expression of these miRNAs was studied 
in naive T-cells, stimulated for 10 days using αCD3/CD28 antibodies. Phenotyping 
revealed gain of CD25 and CD45RO expression upon activation. Analysis of the 
miRNA levels at day 3, 5, 7 and 10 showed clear activation-induced differences in 
the levels of the mature miRNAs. Moreover, we observed miRNA specific early 
and late expression kinetics-patterns. In conclusion, we show a complex network 
of regulatory mechanisms controlling differential timing and level of specific T cell 
activation associated miRNAs.




Differentiation and maintenance of the immune system requires tight regulation in 
order to control the development and activation state of specialized immune cells. 
This is clearly exemplified in the field of T-cell development, maturation and 
differentiation. Growing evidence indicates that the phenotypic and functional 
diversity of T-cells depends on a complex network of transcription factors, epigenetic 
marks and non-coding RNA transcripts, most notably microRNAs (miRNAs) [1-3]. 
Several studies have shown that proper T-cell development depends on the presence 
of miRNAs [4-6]. Moreover, profiling studies have demonstrated distinct expression 
patterns characterizing specific T-cell subsets and dynamic regulation of multiple 
miRNAs upon external stimuli [7,8]. 
We (Chapter 2) and others [8] have observed that human memory T-cells are 
characterized by a specific miRNA expression signature that is significantly different 
from the signature of antigen inexperienced, naive T-cells. This characteristic miRNA 
expression signature is likely the result of the differential proliferative history and 
maturation stage of memory T-cells. Several of these miRNAs have been functionally 
related to T cell biology. MiR-155 has been shown to regulate T-cell proliferation 
[9-12], development of Th1 and Th17 immune response [9,13-15], and responsiveness 
to type I interferon [10]. In addition, miR-155 has a well described pronounced 
oncogenic potential in B-cells [16,17]. MiR-21 has been shown to inhibit apoptosis 
[18], promote proliferation [19], and regulate the DNA methylation status in T cells 
[20]. MiR-146a inhibits NFκB signaling and as such prevents formation of excessive 
immune responses [21,22]. 
Although T-cell activation has recently been shown to affect miRNA expression 
in naive T-cells [5,23,24], little is known about the kinetics of miRNA regulation. 
We selected four miRNAs, i.e. miR-21, miR-146a, miR-155, and miR-31, that were reported 
to be differentially expressed between naive and memory T-cells (Chapter 2 and [23]) and 
have been previously linked to T cell activation (i.e. miR-146a, miR-155) [25,26].
ResULTs AND DIsCUssIoN
We first sorted naive and memory CD4+ T cells based on CD45RO expression 
(Fig. 1A) and confirmed the differential expression of four selected miRNAs (miR-21, 
miR-146a, miR-155, and miR-31). As a control, we also analyzed expression of 
miR-125a, which we previously found to be expressed at similar levels in naive and 
memory T-cells (see Chapter 2) (Fig. 1B). To assess if and how T-cell activation affects 
the expression of the selected miRNAs, we activated naive CD4+ T-cells using αCD3/
CD28 monoclonal antibodies (mAbs) for 10 days. By day seven after activation we 
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observed that all cells had become blast-like, expressed the IL-2 receptor α-subunit 
(CD25), and had acquired a memory phenotype as determined by the expression 
of CD45RO. These changes are consistent with the expected activation induced 
phenotype  [27] (Figure 1C). 
Using qRT-PCR, we assessed the expression of the four selected miRNAs at 
the indicated time-points after activation. Expression of all four miRNAs underwent 
dynamic changes (Fig. 1D). Overall, the expression of miRNAs specific for T-cells with 
a memory phenotype (miR-21, miR-146a, miR-155) was induced upon activation, 
while the expression of a miRNA specific for T-cells with a naive phenotype (miR-31) 
was downregulated upon activation. This indicates that the activation process 
indeed leads to the acquisition of a memory phenotype-specific miRNA signature. 
Interestingly, we observed that activation-induced expression of the three memory 
T-cell-specific miRNAs followed different kinetics. MiR-21 expression was induced in 
two steps; the first induction lead to a 13 fold increase at day 5, then remained stable 
till day 7 and reached a 35 fold-increase by day 10. MiR-146a induction was observed 
only after 5-days from the start of the activation, after which a rapid induction was 
obtained reaching a 55 fold-increase at day 10. This pattern was consistent with 
previous data published by Curtale et.al [25]. MiR-155 expression was strongly 
induced immediately after activation, confirming the data of Stahl et.al [26], peaked at 
day 7 with a fold increase of 110, followed by a marked decrease at day 10. Although 
these specific patterns of induction indicate different regulatory circuits involved 
in the regulation of miR-21, miR-146a, and miR-155, all three miRNAs have been 
reported to be regulated by NF-κB [22,28-30] (Figure 2). In addition, miR-21 has 
been shown to be under positive transcriptional control of AP1 and STAT3 [31,32], 
while miR-155 has been shown to be under positive transcriptional control of AP1 
[33] and STAT5 [34]. The delayed induction of miR-146a upon activation of human 
T-cells, as observed in this study and by Curtale et. al. [25], indicates involvement 
of an additional regulatory layer controlling the increase of mature miR-146a 
expression. The level of mature miRNA expression can be affected by factors regulating 
primary-miRNA transcript localization and processing, irrespective from the 
transcriptional control [35]. Whether the primary transcript of miR-146a is under 
such regulation upon T-cell activation, remains to be investigated. Expression of 
miR-31, which is high in naive cells and low in memory T-cells, was downregulated 
immediately after activation of the naive cells. This indicates that low miR-31 
levels may be involved in acquisition of the activated memory T-cell phenotype.
The observed differences in timing of miRNA induction suggests that miR-155 
and miR-31 are involved in the initial phase of T-cell activation, while miR-21 and 
miR-146a are involved in a later phase of the activation, or in the termination of 
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Figure 1. T-cell activation induces dynamic changes in miRNA expression. A Representative 
FACS plot depicting the gating strategy used to isolate naive (CD45RO-) and memory (CD45RO+) 
CD4+ T-cells from PBMC of healthy donors. B MiRNA expression in naive and memory T-cell 
populations. MiRNA expression levels were normalized to RNU48. The expression level in naive 
(miR-21, miR -146a, miR-155, miR-125a), or memory (miR-31) T-cells (n=3 to 5 different donors) 
was set to 1. Data are represented as median with interquartile range. C Isolated naive CD4+ T-cells 
were stimulated with αCD3/CD28 mAbs for 7 days. Representative FACS plots depicting changes 
in cell size and expression of the activation markers before and after activation are depicted. D 
Naive CD4+ T-cells were stimulated with αCD3/CD28 mAbs for 10 days. Expression of miR-21, 
miR-146a, miR-155 and miR-31 was analyzed at indicated time points after activation. MiRNA 
expression was normalized to RNU48 and the expression at day 0, i.e. before activation, was set to 1 
(n=3 to 5 different donors). Data are represented as median with interquartile range (dashed lines).
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Figure 2. Dynamic expression of miRNAs co-regulates T-cell activation process. T-cell activation 
involves activation of NF-κB transcription factor, which is subsequently translocated to the nucleus. NF-
κB regulates expression of multiple genes including the activation-induced increase of miR-155, miR-21 
and miR-146a levels. Downregulation of miR-31 expression upon T-cell activation might augment the 
NF-κB activity via upregulation of NIK, a direct target of miR-31. Induced expression of miR-21 and 
miR-155 may support T-cell activation by inhibition of apoptosis and enhancement of proliferation, 
while the induction of miR-146 in a later phase of T-cell activation might lead to the termination 
of the activation state by negatively regulating the NF-κB signaling. Partly based on Nature Reviews 
Immunology, doi:10.1038/nri3494
the activation process. Based on the known functions of miR-155 in T-cell function 
[9-14], miR-155 induction might be involved in enhancement of T-cell proliferation 
and generation of optimal Th1 and Th17 immunity (Figure 2). MiR-31 has been 
shown to repress the NFκB-inducing kinase (NIK) [36], an important positive 
regulator of NFκB pathway in T-cells [37] (Figure 2). This implicates that high miR-
31 levels in naive T-cells contribute to negative regulation of non-canonical NFκB 
signaling, while miR-31 downregulation, observed early upon T-cell activation, 
might be involved in the acquisition of an activated T cell phenotype. MiR-21 has 
been shown to inhibit apoptosis and promote proliferation [18,19], indicating that 
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miR-21 induction is essential to promote survival of activated T-cells. MiR-146a is 
a known inhibitor of NFκB signaling by targeting NF-κB activating factors, such as 
TRAF6 and IRAK1 (Figure 2) and thereby provides a negative regulatory feedback 
pathway to prevent excessive immune activation [21,22]. Thus, the induction 
of miR-146a expression relatively late after T-cell activation is likely associated with 
waning of the activation process and preventing uncontrolled immune reactivity. 
Together, the results presented here show dynamic regulation of miRNAs and 
indicate their contribution to the complex regulatory network of T-cell activation and 
differentiation. This is exemplified by the regulated expression of miR-31, miR-155, 
miR-21 and miR-146a, which may be, respectively, involved in achieving and 
maintaining T cell activation, enhance T cell survival and induce waning of T-cell 
activation. Thus, regulated expression of miRNAs adds to the dynamic and plasticnature 
of T-cells, which is pivotal to well-balanced adaptive immunity and ensures 
eradication of the vast diversity of pathogens while preserving the self-tolerance.
MATeRIALs AND MeThoDs
Isolation of CD4+ T cells
Peripheral blood mononuclear cells (PBMC) from healthy donors were isolated 
by density gradient centrifugation using Lymphoprep (Axis-shield, Oslo, 
Norway) immediately after blood withdrawal into heparin vacutainer tubes 
(Becton Dickinson, Franklin Lakes, USA). Naive (CD4+CD45RO-) and memory 
(CD4+CD45RO+) T-cells were isolated from PBMC by fluorescence-activated cell 
sorting (FACS) (MoFlo, Beckman Coulter, Brea, USA)  using anti-human-CD4 
(Edu-2, IQ Products, Groningen, The Netherlands), and anti-human-CD45RO 
(UCHL1, eBioscience, San Diego, USA).
T-cell activation with αCD3/CD28 mAbs 
TCR stimulation of isolated naive (CD4+CD45RO-) T-cells was performed with 
plate-bound anti-human-CD3 and soluble anti-human-CD28 mAbs. Briefly, 
culture plates were incubated with goat-anti-mouse-IgG2a Ab (Cat. No. 1080-01, 
Southern Biotechnology) overnight at 4°C, followed by washing with PBS and 1h 
incubation with hybridoma-culture supernatant, containing anti-human-CD3 
IgG2a mAb (clone WT32, approx. conc. 1µg IgG/mL) at RT. Unbound anti-CD3 
antibody was removed by washing 4 times with excess PBS, and isolated naive T-cells 
were seeded at a density of 0.5x106 cells/mL in complete medium supplemented 
with 5% V/V hybridoma-culture supernatant containing anti-human CD28 IgG1 
mAb (clone 20-4669), giving about 0.1µg IgG/mL end concentration. Cells were 
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re-stimulated every 2-3 days. At indicated time points, cells were harvested, stained 
for FACS analysis or lysed with Qiazol reagent (Qiagen) and stored at -20°C until 
RNA extraction procedure. 
FACs analysis of cell surface markers
Expression of cell-surface markers on naive T-cells before and after treatment with 
activating stimuli was assessed by FACS using mAbs against human CD45RO-PE 
(UCHL1) and CD25-APC (BC96). Cells were measured on a FACS Calibur flow 
cytometer using Cell Quest software (BD Biosciences). Data were analyzed using the 
Kaluza Flow Analysis Software (Beckman Coulter).
RNA Isolation and qRT-PCR
Total cellular RNA was extracted using the miRNeasy Mini Kit (Qiagen, Venlo, 
The Netherlands) following the manufacturer’s instructions. The RNA quantity was 
measured on a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, 
Wilmington, DE). MiRNA expression levels were analyzed by quantitative reverse-
transcription-polymerase chain reaction (qRT-PCR). RNA was reverse transcribed 
using the Taqman MicroRNA Reverse Transcription kit in combination with 
multiplexed reverse transcription primers of TaqMan microRNA Assays (Life 
Technologies, Carlsbad, USA): for miR-21 (ID: 000397), miR-146a (ID: 000468), 
miR-155 (ID: 002623), miR-125a (ID: 000448), miR-31 (ID: 002279), and RNU48 
(ID: 001006). The qPCR reaction was performed using qPCR MasterMix Plus 
(Eurogentec, Liege, Belgium), and Taqman Gene expression assays. All reactions 
were run in triplicate. Mean cycle threshold (Ct) values for all genes were quantified 
with the Sequence Detection Software (SDS, version 2.3, Life Technologies), using 
ABI7900HT thermo cycler (Life Technologies). RNU48 served as an endogenous 
control. Relative expression levels were determined using the 2-ΔCt formula, where 
ΔCt = Ctgene – Ctref.gene.  
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